The deal size was increased to $275M in common stock from $250M in common stock and the range was $28.80-$30.00. Goldman Sachs, JPMorgan, TD Cowen and Guggenheim acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SWTX:
- SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
- SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock
- Biotech Alert: Searches spiking for these stocks today
- SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
- SpringWorks Therapeutics price target raised to $73 from $64 at H.C. Wainwright
